Almon Einat Brill

CIK 00013851161 companyCARMIEL, L3

SEC Profile

Transactions

Companies

Filings

CIK

0001385116

Recent Transactions

37 trades

Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2020-06-07+196,995→ 196,995 total
Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2018-09-13+700,000→ 700,000 total
Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2015-03-23+250,000→ 250,000 total
Award
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2012-07-16+185,000→ 185,000 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2012-05-02$7.13/sh−166,848→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2012-05-02−50,000→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2012-05-02$2.65/sh+50,000→ 166,848 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2012-05-02−116,848→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2012-05-02$0.97/sh+116,848→ 116,848 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-10-06$0.97/sh+70,000→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-10-06$9.29/sh−15,000→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2010-10-06−70,000→ 116,848 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-10-05$9.08/sh−20,000→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-10-04$9.02/sh−35,000→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2010-09-07−45,260→ 186,848 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-09-07$0.40/sh+4,740→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2010-09-07−4,740→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-09-07$0.97/sh+45,260→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-09-07$8.16/sh−22,500→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-09-03$8.00/sh−27,500→ 0 total
Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2010-02-25+130,000→ 130,000 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-10-19$9.43/sh−38,320→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-10-19$0.40/sh+93,954→ 0 total
Tax Payment
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-10-19$9.48/sh−3,954→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2009-10-19−93,954→ 4,740 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-10-16$9.39/sh−23,680→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-10-15$9.39/sh−28,000→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-07-07$4.95/sh−11,000→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-07-07$0.40/sh+59,822→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2009-07-07−59,822→ 98,694 total
Tax Payment
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-07-07$4.95/sh−4,822→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-07-06$5.13/sh−44,000→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-05-18$0.40/sh+44,707→ 44,707 total
Tax Payment
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-05-18$3.79/sh−4,707→ 40,000 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2009-05-18−44,707→ 158,516 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-05-18$4.00/sh−40,000→ 0 total
Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2009-02-25+50,000→ 50,000 total

Companies

Protalix BioTherapeutics, Inc.
VP, Product Development
$PLX

Recent Filings

Address

C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET, SCIENCE PARK, POB 455

CARMIEL, L3, 20100

View on SEC.gov